newsfilter
← Latest News
GlobeNewswire·

First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.0 Million Gross Proceeds Priced At-the-Market

BOCA RATON, Fla., Sept. 14, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. ("First Wave BioPharma" or the "Company") (NASDAQ:FWBI), a clinical-stage biopharmaceutical company specializing in the development of